All filters
Slidesets
HIV integrase Inhibitors: A novel mechanisms of action | Francisco Flores Murrieta, PhD
Presented at:
Mexican HIV Clinical Forum 2018
Slidesets
Clinical case presentation | Santiago Pérez Patrigeon, PhD
Presented at:
Mexican HIV Clinical Forum 2018
Slidesets
Clinical case presentation | Aurelio Orta. MD
Presented at:
Mexican HIV Clinical Forum 2018
Slidesets
Pharmacological Characteristics and Delivery Options of the Integrase Inhibitors | Courtney Fletcher, PharmD
Presented at:
Mexican HIV Clinical Forum 2018
Meeting
Mexican HIV Clinical Forum 2018
Slidesets
INSTIs in women and pregnancy | Sharon Walmsley, FRCPC, MD, MSC
Presented at:
Rio de Janeiro HIV Clinical Forum 2018
Slidesets
HIV prevention and the role of integrase inhibitors | Pep Coll, MD
Presented at:
Rio de Janeiro HIV Clinical Forum 2018
Slidesets
Clinical case presentation | Marcio de Figueiredo Fernandes, MD
Presented at:
Rio de Janeiro HIV Clinical Forum 2018
Slidesets
SIERJ SESSION: Is early ART for everyone? | Mauro Schechter, MD, PhD
Presented at:
Rio de Janeiro HIV Clinical Forum 2018
Slidesets
Clinical case presentation | Tânia Vergara, MD, PhD
Presented at:
Rio de Janeiro HIV Clinical Forum 2018
Slidesets
Optimal use of INSTI’s in routine practice | Carlos Brites, MD, PhD
Presented at:
Rio de Janeiro HIV Clinical Forum 2018
Slidesets
Simplified regimens: pros and cons | Pedro Cahn, MD, PhD
Presented at:
Rio de Janeiro HIV Clinical Forum 2018
Slidesets
Future perspective for delivery of antiretroviral drugs | David Back, PhD
Presented at:
Rio de Janeiro HIV Clinical Forum 2018
Slidesets
Resistance to Integrase Inhibitors | Charles Boucher, MD, PhD
Presented at:
Rio de Janeiro HIV Clinical Forum 2018
Slidesets
Transmitted resistance to ARVs and its impact on initial therapy | Ricardo Diaz, MD
Presented at:
Rio de Janeiro HIV Clinical Forum 2018
Slidesets
DDIs, INSTIs, TB and hepatitis | David Back, PhD
Presented at:
Rio de Janeiro HIV Clinical Forum 2018
Slidesets
What is the Virological support for reduced drug regimens? | Daniel Kuritzkes, MD
Presented at:
Global HIV Clinical Forum 2018
Slidesets
What is the Pharmacological support for reduce drug regimens? | David Back, PhD
Presented at:
Global HIV Clinical Forum 2018
Slidesets
Expanding Integrase Inhibitors in the rest of Europe | Miłosz Parczewski, MD, PhD
Presented at:
Global HIV Clinical Forum 2018
Slidesets
Implication of the resent Dolutegravir data | Rebecca Zash, MD
Presented at:
Global HIV Clinical Forum 2018
Slidesets
Clinical case: Integrase Inhibitors in Africa | Julia Turner, MD
Presented at:
Global HIV Clinical Forum 2018
Slidesets
Designing e-health interventions for HIV care | Guido van den Berk, MD, PhD
Presented at:
Global HIV Clinical Forum 2018
Slidesets
State of the ART: Integrase Inhibitors (clinical overview) | Mauro Schechter, MD, PhD
Presented at:
Global HIV Clinical Forum 2018